NextCure, Inc.
NXTC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $21,556 | $31,734 | $39,119 | $165,696 |
| - Cash | $27,727 | $13,082 | $26,630 | $12,337 |
| + Debt | $5,949 | $6,605 | $7,123 | $0 |
| Enterprise Value | -$222 | $25,257 | $19,612 | $153,359 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$54,341 | -$63,953 | -$71,785 | -$66,588 |
| % Margin | – | – | – | – |
| Net Income | -$55,654 | -$62,723 | -$74,733 | -$69,389 |
| % Margin | – | – | – | – |
| EPS Diluted | -23.88 | -27.039 | -32.324 | -30.152 |
| % Growth | 11.7% | 16.3% | -7.2% | – |
| Operating Cash Flow | -$40,805 | -$52,974 | -$53,886 | -$57,244 |
| Capital Expenditures | -$474 | -$820 | -$2,116 | -$2,360 |
| Free Cash Flow | -$41,279 | -$53,794 | -$56,002 | -$59,604 |